Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

113 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transatlantic Consensus Group on active surveillance and focal therapy for prostate cancer.
Ahmed HU, Akin O, Coleman JA, Crane S, Emberton M, Goldenberg L, Hricak H, Kattan MW, Kurhanewicz J, Moore CM, Parker C, Polascik TJ, Scardino P, van As N, Villers A; Transatlantic Consensus Group on Active Surveillance and Focal Therapy for Prostate Cancer (appendix). Ahmed HU, et al. Among authors: goldenberg l. BJU Int. 2012 Jun;109(11):1636-47. doi: 10.1111/j.1464-410X.2011.10633.x. Epub 2011 Nov 11. BJU Int. 2012. PMID: 22077593 Free PMC article.
A multi-institutional evaluation of active surveillance for low risk prostate cancer.
Eggener SE, Mueller A, Berglund RK, Ayyathurai R, Soloway C, Soloway MS, Abouassaly R, Klein EA, Jones SJ, Zappavigna C, Goldenberg L, Scardino PT, Eastham JA, Guillonneau B. Eggener SE, et al. Among authors: goldenberg l. J Urol. 2009 Apr;181(4):1635-41; discussion 1641. doi: 10.1016/j.juro.2008.11.109. Epub 2009 Feb 23. J Urol. 2009. PMID: 19233410 Free PMC article.
A multi-institutional evaluation of active surveillance for low risk prostate cancer.
Eggener SE, Mueller A, Berglund RK, Ayyathurai R, Soloway C, Soloway MS, Abouassaly R, Klein EA, Jones SJ, Zappavigna C, Goldenberg L, Scardino PT, Eastham JA, Guillonneau B. Eggener SE, et al. Among authors: goldenberg l. J Urol. 2013 Jan;189(1 Suppl):S19-25; discussion S25. doi: 10.1016/j.juro.2012.11.023. J Urol. 2013. PMID: 23234624
Waterjet Ablation Therapy for Endoscopic Resection of prostate tissue trial (WATER) vs WATER II: comparing Aquablation therapy for benign prostatic hyperplasia in 30-80 and 80-150 mL prostates.
Nguyen DD, Barber N, Bidair M, Gilling P, Anderson P, Zorn KC, Badlani G, Humphreys M, Kaplan S, Kaufman R, So A, Paterson R, Goldenberg L, Elterman D, Desai M, Lingeman J, Roehrborn C, Bhojani N. Nguyen DD, et al. Among authors: goldenberg l. BJU Int. 2020 Jan;125(1):112-122. doi: 10.1111/bju.14917. Epub 2019 Nov 8. BJU Int. 2020. PMID: 31599044 Free PMC article.
Aquablation for benign prostatic hyperplasia in large prostates (80-150 mL): 6-month results from the WATER II trial.
Desai M, Bidair M, Zorn KC, Trainer A, Arther A, Kramolowsky E, Doumanian L, Elterman D, Kaufman RP Jr, Lingeman J, Krambeck A, Eure G, Badlani G, Plante M, Uchio E, Gin G, Goldenberg L, Paterson R, So A, Humphreys M, Roehrborn C, Kaplan S, Motola J, Bhojani N. Desai M, et al. Among authors: goldenberg l. BJU Int. 2019 Aug;124(2):321-328. doi: 10.1111/bju.14703. Epub 2019 Mar 29. BJU Int. 2019. PMID: 30734990 Clinical Trial.
WATER II (80-150 mL) procedural outcomes.
Desai M, Bidair M, Bhojani N, Trainer A, Arther A, Kramolowsky E, Doumanian L, Elterman D, Kaufman RP Jr, Lingeman J, Krambeck A, Eure G, Badlani G, Plante M, Uchio E, Gin G, Goldenberg L, Paterson R, So A, Humphreys M, Roehrborn C, Kaplan S, Motola J, Zorn KC. Desai M, et al. Among authors: goldenberg l. BJU Int. 2019 Jan;123(1):106-112. doi: 10.1111/bju.14360. Epub 2018 Jun 10. BJU Int. 2019. PMID: 29694702 Clinical Trial.
113 results